MusclePharm Corporation MSLP OTC

Other OTC • Consumer Defensive • Packaged Foods • US • USD

SharesGrow Score

11/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

MusclePharm Corporation (MSLP) reported total assets of $11.21M and total liabilities of $43.4M for fiscal year 2021, resulting in total equity of $-32.19M.

The company held $1.22M in cash and short-term investments. Total debt stood at $10.71M, with net debt of $9.48M. The Debt-to-Equity (D/E) ratio was -0.33 (conservative).

Current ratio is 0.27, which may signal tight short-term liquidity. Interest coverage is -1.4x (weak).

Criteria supported by this page:

HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (7/100) — Total assets $11.21M and equity $-32.19M support the company's competitive scale

Overall SharesGrow Score: 11/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

11/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

25/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

7/100

→ Income

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

MusclePharm Corporation Balance Sheet History

Metric	FY2021	FY2020	FY2019	FY2018
Total Assets	$11.21M	$13M	$14.54M	$24.6M
Total Liabilities	$43.4M	$37.42M	$42.49M	$52.8M
Total Debt	$10.71M	$11.44M	$11.28M	$20.73M
Cash & Investments	$1.22M	$2M	$1.53M	$2.32M
Total Stockholders Equity	$-32.19M	$-24.42M	$-27.95M	$-28.2M